These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Metastases of unknown primary site. Lembersky BC; Thomas LC Med Clin North Am; 1996 Jan; 80(1):153-71. PubMed ID: 8569295 [TBL] [Abstract][Full Text] [Related]
23. Use of immunocytochemistry in the diagnosis of metastatic carcinoma. Matthews P; Ellis IO Ann Med; 1996 Aug; 28(4):297-300. PubMed ID: 8862682 [TBL] [Abstract][Full Text] [Related]
24. A Rare Case of Synchronous Papillary Microcarcinoma and Metastatic Neuroendocrine Tumor of Unknown Primary. Roy SG; Tripathy S; Parida GK; Agarwal S; Bal C Indian J Nucl Med; 2018; 33(1):59-61. PubMed ID: 29430119 [TBL] [Abstract][Full Text] [Related]
26. Are time or intensity factors important to the definition of metastases of unknown origin? Abbruzzese JL; Abbruzzese MC; Lenzi R; Raber MN; Hess KR J Natl Cancer Inst; 1996 Apr; 88(7):462-3. PubMed ID: 8618241 [No Abstract] [Full Text] [Related]
27. Diagnostic, Theranostic and Prognostic Value of Thyroglobulin in Thyroid Cancer. Giovanella L; D'Aurizio F; Petranović Ovčariček P; Görges R J Clin Med; 2024 Apr; 13(9):. PubMed ID: 38730992 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of the patient with carcinoma of unknown origin metastatic to bone. Rougraff BT Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S105-9. PubMed ID: 14600599 [TBL] [Abstract][Full Text] [Related]
29. Metastatic dormancy and progression in thyroid cancer: targeting cells in the metastatic frontier. Ringel MD Thyroid; 2011 May; 21(5):487-92. PubMed ID: 21476892 [TBL] [Abstract][Full Text] [Related]
30. Clinical utility of serum thyroglobulin in metastatic disease. Shah DH; Kumar A; Vijayan U; Dandekar SR; Krishna BA; Rao RS Indian J Med Res; 1994 Nov; 100():232-6. PubMed ID: 7829158 [TBL] [Abstract][Full Text] [Related]
31. Detection of thyroglobulin in fine needle aspirates of nonthyroidal neck masses: a clue to the diagnosis of metastatic differentiated thyroid cancer. Pacini F; Fugazzola L; Lippi F; Ceccarelli C; Centoni R; Miccoli P; Elisei R; Pinchera A J Clin Endocrinol Metab; 1992 Jun; 74(6):1401-4. PubMed ID: 1592886 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery. Makarewicz J; Adamczewski Z; Knapska-Kucharska M; Lewiński A Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):485-9. PubMed ID: 17115345 [TBL] [Abstract][Full Text] [Related]
33. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma. Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882 [TBL] [Abstract][Full Text] [Related]
34. Serum thyroglobulin in the investigation of patients presenting with metastases. Edmonds CJ; Willis CL Br J Radiol; 1988 Apr; 61(724):317-9. PubMed ID: 3370417 [TBL] [Abstract][Full Text] [Related]